Fecal matter for prevention or treatment of autoimmune diseases

Max Nieuwdorp (Inventor), W.M. de Vos (Inventor)

Research output: PatentOther research output


The present invention relates to the use of fecal matter in the treatment of a subject having autoimmune disease, wherein the fecal matter is autologous to the subject, and preferably administered to the small intestine, preferably the duodenum, of the subject. The fecal matter can be one or more constituents of autologous feces, preferably chosen from the group consisting of bacteria, viruses, bacteriophages, fungi, metabolites, microRNAs, proteins, antibodies, and/or antigens.
Original languageEnglish
Patent numberWO2019168401
Priority date20/07/18
Publication statusPublished - 6 Sep 2019

Fingerprint Dive into the research topics of 'Fecal matter for prevention or treatment of autoimmune diseases'. Together they form a unique fingerprint.

Cite this